Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
International Journal of Drug Discovery and Pharmacology is Scopus-indexed (Q4, CiteScore 1.7), DOAJ. Published by Scilight Press Pty. Ltd.
Checked against the index lists dated .
ISSN 2653-6234Verify ISSN ↗
Publisher: Scilight Press Pty. Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 248 / 328 | 24th | Q4 |
| Drug Discovery | 133 / 161 | 17th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q4, CiteScore 1.7.
International Journal of Drug Discovery and Pharmacology is Q4 in Pharmacology (rank 248 of 328) and Q4 in Drug Discovery (rank 133 of 161), by CiteScore 2025.
International Journal of Drug Discovery and Pharmacology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.7, quartile Q4, 24th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.316, quartile Q3, with an H-index of 8.
International Journal of Drug Discovery and Pharmacology is published by Scilight Press Pty. Ltd. Its ISSN is 2653-6234.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
International Journal of Drug Discovery and Pharmacology has an h-index of 8 and a 2-year mean of 1.28 citations per paper (OpenAlex). Its Scopus CiteScore is 1.7, quartile Q4. On 2-year citations it ranks #216 of 319 Scopus journals in Pharmacology.
International Journal of Drug Discovery and Pharmacology published 25 papers in 2025; its busiest recent year was 2023 with 25. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 80 research articles (2022–2026), authors are most often from China (49.5%), United Kingdom (18.9%) and United States (13.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.